ISSN: 2165-7025

新規理学療法ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • 索引コペルニクス
  • Google スカラー
  • Jゲートを開く
  • Genamics JournalSeek
  • アカデミックキー
  • セーフティライト付き
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ICMJE
このページをシェアする

抽象的な

Therapeutic Ultrasound and Photobiomodulation Applied on the Palm of Hands: A New Treatment for Fibromyalgia?A Man Case Study

Daniel Marques Franco, Juliana da Silva Amaral Bruno, Anderson Luis Zanchin, Heloisa Ciol, Vanderlei Salvador Bagnato and Antonio Eduardo de Aquino Junior

Fibromyalgia is a chronic disorder put in the spotlight in the last decades. Known since the 1920s, the disease is described by multiple painful points, of heightened sensitivity to touch that prevails in women, and afflict 3% to 10% of worldwide population. Fibromyalgia affects skeletal muscles and soft tissues. However, although there is no joint pain. Pharmacological treatment consists in analgesics and anti-inflammatory drugs to ease the pain. In addition, antidepressants, anxiolytics and anticonvulsants can be prescribed to control pain crises. Non-pharmacological approaches as therapeutic ultrasound and photobiomodulation are an alternative for pain relief. Recently, the synergic action of therapeutic ultrasound and photobiomodulation has emerged as an alternative to treat fibromyalgia in women when applied at the palm of hands. The success of the treatment is attributed to stimulation of neuroreceptors close to blood vessels located at the palm of hands and found to be in higher incidence in fibromyalgic patients when compared to healthy patients. This study aimed to evaluate the synergic effect of therapeutic ultrasound and photobiomodulation applied to the palm of hands of a fibromyalgic man patient. Evaluation was based on Quality Life Questionnaire (SF-36) and Visual Analogue Scale (VAS). Results show the treatment could improve the patient’s quality of life (SF-36) and reduce pain (VAS), indicating a new therapeutic approach to treat chronic disorders like fibromyalgia, reducing pain and increasing quality of life of fibromyalgic patients.